BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.095
-0.325 (-13.43%)
At close: Jun 24, 2026, 4:00 PM EDT
2.100
+0.005 (0.24%)
Pre-market: Jun 25, 2026, 5:19 AM EDT

BioNexus Gene Lab Market Cap

BioNexus Gene Lab has a market cap or net worth of $5.06 million as of June 25, 2026. Its market cap has decreased by -9.07% in one year.

Market Cap
5.06M
Enterprise Value
1.45M
1-Year Change
-9.07%
Ranking
Category
Stock Price
$2.10

Market Cap Chart

Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.06M, a decrease of -87.98%. That is a compound annual growth rate of -30.72%.

History

DateMarket Cap% Change
Jun 24, 20265.06M-45.76%
Dec 31, 20259.34M85.79%
Dec 31, 20245.03M-46.33%
Dec 29, 20239.36M-94.33%
Dec 30, 2022165.03M-54.75%
Dec 31, 2021364.69M54.35%
Dec 31, 2020 Pro Pro
Sep 16, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition